<DOC>
	<DOC>NCT01196884</DOC>
	<brief_summary>Primary ITP has wide heterogenous biology, presentation and response to therapy. The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.</brief_summary>
	<brief_title>Immune Thrombocytopenia (ITP) Immune-Genetic Assessment</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura, Thrombocytopenic, Idiopathic</mesh_term>
	<criteria>Adult patients with primary ITP Secondary ITP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Patients with primary Immune Thrombocytopenia (ITP)</keyword>
</DOC>